Comparison of radiolabeled isatin analogs for imaging apoptosis with positron emission tomography

Mach, 2005, Functional imaging of cellular death, 327 Yanga, 2008, Dysfunction of pulmonary vascular endothelium in chronic obstructive pulmonary disease: basic considerations for future drug development, Curr Drug Metab, 9, 661, 10.2174/138920008785821684 Aneja, 2008, Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic options, Am J Med, 121, 748, 10.1016/j.amjmed.2008.03.046 Cook, 2004, B cell biology, apoptosis, and autoantibodies to phospholipids, Thromb Res, 114, 307, 10.1016/j.thromres.2004.06.037 Friedlander, 2003, Apoptosis and caspases in neurodegenerative diseases, N Engl J Med, 348, 1365, 10.1056/NEJMra022366 Reed, 2004, Apoptosis mechanisms: implications for cancer drug discovery, Oncology (Williston Park), 18, 11 Zeitlin, 2008, Expanding circle of inhibition: small-molecule inhibitors of Bcl-2 as anticancer cell and antiangiogenic agents, J Clin Oncol, 26, 4180, 10.1200/JCO.2007.15.7693 Green, 2005, Apoptotic pathways: ten minutes to dead, Cell, 121, 671, 10.1016/j.cell.2005.05.019 Thornberry, 1998, Caspases: enemies within, Science, 281, 1312, 10.1126/science.281.5381.1312 Broker, 2005, Cell death independent of caspases: a review, Clin Cancer Res, 11, 3155, 10.1158/1078-0432.CCR-04-2223 Kitanaka, 1999, Caspase-independent programmed cell death with necrotic morphology, Cell Death Differ, 6, 508, 10.1038/sj.cdd.4400526 Salvesen, 1997, Caspases: intracellular signaling by proteolysis, Cell, 91, 443, 10.1016/S0092-8674(00)80430-4 Vaux, 1996, The molecular biology of apoptosis, Proc Natl Acad Sci U S A, 93, 2239, 10.1073/pnas.93.6.2239 Elmore, 2007, Apoptosis: a review of programmed cell death, Toxicol Pathol, 35, 495, 10.1080/01926230701320337 Chapman, 2002, A novel nonpeptidic caspase-3/7 inhibitor, (S)-(+)-5-[1-(2-methoxymethylpyrrolidinyl)sulfonyl]isatin reduces myocardial ischemic injury, Eur J Pharmacol, 456, 59, 10.1016/S0014-2999(02)02484-6 Lee, 2000, Potent and selective nonpeptide inhibitors of caspases 3 and 7 inhibit apoptosis and maintain cell functionality, J Biol Chem, 275, 16007, 10.1074/jbc.275.21.16007 Zhou, 2006, Synthesis, radiolabeling, and in vivo evaluation of an 18F-labeled isatin analog for imaging caspase-3 activation in apoptosis, Bioorg Med Chem Lett, 16, 5041, 10.1016/j.bmcl.2006.07.045 Faust, 2007, The nonpeptidyl caspase binding radioligand (S)-1-(4-(2-[18F]fluoroethoxy)-benzyl)-5-[1-(2-methoxymethylpyrrolidinyl)sulfonyl]isatin ([18F]CbR) as potential positron emission tomography-compatible apoptosis imaging agent, Q J Nucl Med Mol Imaging, 51, 67 Zhou, 2009, [18F] and [11C]N-benzyl-isatin sulfonamide analogues as PET tracers for apoptosis: synthesis, radiolableing mechanism, and in vivo imaging study of apoptosis in Fas-treated mice using [11C]WC-98, Org Biomol Chem, 7, 1337, 10.1039/b819024k Faa, 1994, An electron microscopic study of apoptosis induced by cycloheximide in rat liver, Liver, 14, 270, 10.1111/j.1600-0676.1994.tb00087.x Ledda-Columbano, 1992, Rapid induction of apoptosis in rat liver by cycloheximide, Am J Pathol, 140, 545 Kumar, 2004, Measurement of caspase activity in cells undergoing apoptosis, 19 Holm, 1979, A simple sequentially rejective Bonferroni test procedure, Scand Stat Theory Appl, 6, 65 Blankenberg, 1998, In vivo detection and imaging of phosphatidylserine expression during programmed cell death, Proc Natl Acad Sci U S A, 95, 6349, 10.1073/pnas.95.11.6349 Yagle, 2005, Evaluation of 18F-annexin V as a PET imaging agent in an animal model of apoptosis, J Nucl Med, 46, 658 Zeng, 2008, Synthesis, biological evaluation and radiochemical labeling of a dansylhydrazone derivative as a potential imaging agent for apoptosis, Bioorg Med Chem Lett, 18, 3573, 10.1016/j.bmcl.2008.05.002